Synergistic actions of microglia and astrocytes in the progression of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 45, Issue 4, 2015, Pages 1001-1014

  Bouvier, David S ^a   Murai, Keith K ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Activation; degeneration; glia; inflammation; plaque; reactivity

Indexed keywords

AMYLOID BETA PROTEIN; BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; INTERMEDIATE FILAMENT PROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN REGION; CELL ACTIVITY; CELL COMMUNICATION AND CELL CONTACT; CELL DEATH; CELL DIFFERENTIATION; CELL POLARITY; CELL STRUCTURE; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; BRAIN; IMMUNOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BRAIN; DISEASE PROGRESSION; HUMANS; MICROGLIA;

EID: 84928156948     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-143156     Document Type: Review

References (199)

1. Alzheimer A (Psych) (1911) Über eigenartige Krankheitsf älle des späteren Alters. Z Ges Neurol 4, 356-385.
2. Garcia-Marin V, Garcia-Lopez P, Freire M (2007) Cajal's contributions to the study of Alzheimer's disease. J Alzheimers Dis 12, 161-174.
3. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222.
4. SofroniewMV, Vinters HV (2010) Astrocytes: Biology and pathology. Acta Neuropathol 119, 7-35.
5. Tremblay ME, Stevens B, Sierra A,Wake H, Bessis A, Nimmerjahn A (2011) The role of microglia in the healthy brain. J Neurosci 31, 16064-16069.
6. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845.
7. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86-90.
8. Kettenmann H, Hanisch UK, Noda M,VerkhratskyA(2011) Physiology of microglia. Physiol Rev 91, 461-553.
9. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318.
10. Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: New roles for the synaptic stripper. Neuron 77, 10-18.
11. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J (2013) Microglia: Actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 36, 209-217.
12. Oberheim NA, Goldman SA, NedergaardM(2012) Heterogeneity of astrocytic form and function. Methods Mol Biol 814, 23-45.
13. Oberheim NA, Wang X, Goldman S, Nedergaard M (2006) Astrocytic complexity distinguishes the human brain. Trends Neurosci 29, 547-553.
14. Verkhratsky A, Parpura V (2010) Recent advances in (patho)physiology of astroglia. Acta Pharmacol Sin 31, 1044-1054.
15. Bushong EA, Martone ME, Jones YZ, Ellisman MH (2002) Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 22, 183-192.
16. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: The revolution continues. Nat Rev Neurosci 6, 626-640.
17. Witcher MR, Kirov SA, Harris KM (2007) Plasticity of perisynaptic astroglia during synaptogenesis in the mature rat hippocampus. Glia 55, 13-23.
18. Perea G, Navarrete M, Araque A (2009) Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci 32, 421-431.
19. Araque A (2008) Astrocytes process synaptic information. Neuron Glia Biol 4, 3-10.
20. Araque A, Carmignoto G, Haydon PG, Oliet SH, Robitaille R, Volterra A (2014) Gliotransmitters travel in time and space. Neuron 81, 728-739.
21. Di Castro MA, Chuquet J, Liaudet N, Bhaukaurally K, Santello M, Bouvier D, Tiret P, Volterra A (2011) Local Ca2+ detection and modulation of synaptic release by astrocytes. Nat Neurosci 14, 1276-1284.
22. Henneberger C, Papouin T, Oliet SH, Rusakov DA (2010) Long-term potentiation depends on release of D-serine from astrocytes. Nature 463, 232-236.
23. Jourdain P, Bergersen LH, Bhaukaurally K, Bezzi P, Santello M, Domercq M, Matute C, Tonello F, Gundersen V, Volterra A (2007) Glutamate exocytosis from astrocytes controls synaptic strength. Nat Neurosci 10, 331-339.
24. Panatier A, Vallee J, Haber M, Murai KK, Lacaille JC, Robitaille R (2011) Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 146, 785-798.
25. Burda JE, Sofroniew MV (2014) Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81, 229-248.
26. Hamby ME, Sofroniew MV (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7, 494-506.
27. Streit WJ, Walter SA, Pennell NA (1999) Reactive microgliosis. Prog Neurobiol 57, 563-581.
28. Hanisch UK, Kettenmann H (2007) Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10, 1387-1394.
29. Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL (2005) Role of microglia in the central nervous system's immune response. Neurol Res 27, 685-691.
30. Cherry JD, Olschowka JA, O'Banion MK (2014) Neuroinflammation and M2 microglia: The good, the bad, and the inflamed. J Neuroinflammation 11, 98.
31. Mittelbronn M (2014) The M1/M2 immune polarization concept in microglia: A fair transfer? Neuroimmunol Neuroinflamm 1, 6-7.
32. Sofroniew MV (2014) Astrogliosis. Cold Spring Harb Perspect Biol, 2014 Nov 7;7(2).
33. Jones EV, Bouvier DS (2014) Astrocyte-secreted matricellular proteins in cns remodelling during development and disease. Neural Plast 2014, 321209.
34. von Bernhardi R, Eugenin J (2004) Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 1025, 186-193.
35. Li C, Zhao R, Gao K,WeiZ,YinMY, LauLT, Chui D, HoiYu AC (2011) Astrocytes: Implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res 8, 67-80.
36. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 25, 663-674.
37. Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32, 638-647.
38. Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ (2000) Microglia, amyloid and dementia in Alzheimer disease. A correlative study. Neurobiol Aging 21, 39-47.
39. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24, 173-182.
40. Mackenzie IR, Hao C, Munoz DG (1995) Role of microglia in senile plaque formation. Neurobiol Aging 16, 797-804.
41. Miyazono M, Iwaki T, Kitamoto T, Kaneko Y, Doh-ura K, Tateishi J (1991) A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol 139, 589-598.
42. Stalder M, Phinney A, Probst A, Sommer B, Staufenbiel M, Jucker M (1999) Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol 154, 1673-1684.
43. Wegiel J, Wang KC, Imaki H, Rubenstein R, Wronska A, Osuchowski M, Lipinski WJ, Walker LC, LeVine H (2001) The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging 22, 49-61.
44. Wegiel J,Wang KC, Tarnawski M, Lach B (2000) Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol 100, 356-364.
45. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM (1998) Microglial response to amyloid plaquesinAPPswtransgenicmice.AmJPathol152,307-317.
46. Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE,Kohsaka S, Jucker M, CalhounME(2008) Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci 28, 4283-4292.
47. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502.
48. Stalder M, Deller T, Staufenbiel M, Jucker M (2001) 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: No evidence of intracellular amyloid. Neurobiol Aging 22, 427-434.
49. Wegiel J,WisniewskiHM(1990) The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol 81, 116-124.
50. Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G (2003) Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci 23, 7504-7509.
51. Matsumura A, Suzuki S, Iwahara N, Hisahara S, Kawamata J, Suzuki H, Yamauchi A, Takata K, Kitamura Y, Shimohama S (2015) Temporal changes of CD68 and alpha7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models. J Alzheimers Dis 44, 409-423.
52. Serrano-Pozo A, Gomez-Isla T, Growdon JH, Frosch MP, HymanBT(2013)Aphenotypic change but not proliferation underlies glial responses in Alzheimer disease. Am J Pathol 182, 2332-2344.
53. Duffy PE, Rapport M, Graf L (1980) Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 30, 778-782.
54. KamphuisW, Middeldorp J,Kooijman L, Sluijs JA,Kooi EJ, Moeton M, Freriks M, Mizee MR, Hol EM (2014) Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiol Aging 35, 492-510.
55. Le Prince G, Delaere P, Fages C, Duyckaerts C, Hauw JJ, Tardy M (1993) Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type. Neurosci Lett 151, 71-73.
56. Porchet R, Probst A, Bouras C, Draberova E, Draber P, Riederer BM (2003) Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease. Proteomics 3, 1476-1485.
57. Mori T, Koyama N, Arendash GW, Horikoshi-Sakuraba Y, Tan J, Town T (2010) Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia 58, 300-314.
58. Mrak RE, Griffinbc WS (2001) The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol Aging 22, 915-922.
59. Mrak RE, Sheng JG, Griffin WS (1996) Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 55, 273-279.
60. Park R, Kook SY, Park JC, Mook-Jung I (2014) Abeta1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-kappaB signaling. Cell Death Dis 5, e1299.
61. Yang J, Lunde LK, Nuntagij P, OguchiT, Camassa LM, Nilsson LN, Lannfelt L, Xu Y, Amiry-Moghaddam M, Ottersen OP, Torp R (2011) Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease. J Alzheimers Dis 27, 711-722.
62. Marlatt MW, Bauer J, Aronica E, van Haastert ES, Hoozemans JJ, Joels M, Lucassen PJ (2014) Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition. Neural Plas 2014, 693851.
63. Mohamed A, Posse de Chaves E (2011) Abeta internalization by neurons and glia. Int J Alzheimers Dis 2011, 127984.
64. Prokop S, Miller KR, Heppner FL (2013) Microglia actions in Alzheimer's disease. Acta Neuropathol 126, 461-477.
65. Doens D, Fernandez PL (2014) Microglia receptors and their implications in the response to amyloid beta for Alzheimer's disease pathogenesis. J Neuroinflammation 11, 48.
66. Avila-Munoz E, Arias C (2014) When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease. Ageing Res Rev 18C 29-40.
67. McGeer PL, McGeer EG (2013) The amyloid cascadeinflammatory hypothesis of Alzheimer disease: Implications for therapy. Acta Neuropathol 126, 479-497.
68. Lee CY, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117, 949-960.
69. Liu S, LiuY, HaoW,Wolf L, Kiliaan AJ, Penke B, Rube CE, Walter J, HenekaMT, Hartmann T, Menger MD, Fassbender K (2012) TLR2 is a primary receptor for Alzheimer's amyloid beta peptide to trigger neuroinflammatory activation. J Immunol 188, 1098-1107.
70. Cartier N, Lewis CA, Zhang R, Rossi FM (2014) The role of microglia in human disease: Therapeutic tool or target? Acta Neuropathol 128, 363-380.
71. Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28, 8354-8360.
72. Christie RH, Bacskai BJ, Zipfel WR, Williams RM, Kajdasz ST, Webb WW, Hyman BT (2001) Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy. J Neurosci 21, 858-864.
73. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13, 432-438.
74. Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, Miller KR, Prokop S, Kettenmann H, Heppner FL (2013) Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 8, e60921.
75. Orre M, Kamphuis W, Osborn LM, Jansen AH, Kooijman L, Bossers K, Hol EM (2014) Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol Aging 35, 2746-2760.
76. Grathwohl SA, Kalin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, Eldh T, Gandy S, Aguzzi A, Staufenbiel M, Mathews PM, Wolburg H, Heppner FL, Jucker M (2009) Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12, 1361-1363.
77. Alarcon R, Fuenzalida C, Santibanez M, von Bernhardi R (2005) Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem 280, 30406-30415.
78. Mulder SD, Veerhuis R, Blankenstein MA, Nielsen HM (2012) The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes. Exp Neurol 233, 373-379.
79. Allaman I, Gavillet M, Belanger M, Laroche T, Viertl D, Lashuel HA, Magistretti PJ (2010) Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: Impact on neuronal viability. J Neurosci 30, 3326-3338.
80. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10, 719-726.
81. Nielsen HM, Mulder SD, Belien JA, Musters RJ, Eikelenboom P, Veerhuis R (2010) Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Glia 58, 1235-1246.
82. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S (2009) Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 57, 978-988.
83. Pihlaja R,Koistinaho J, Malm T, Sikkila H,Vainio S,KoistinahoM( 2008)Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Glia 56, 154-163.
84. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, TooyomaI, VanMuiswinkel FL,Veerhuis R,Walker D,Webster S, Wegrzyniak B,Wenk G,Wyss-CorayT(2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421.
85. Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: Inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012, 756357.
86. Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer's disease: Molecule mechanisms. Int J Dev Neurosci 24, 167-176.
87. Wyss-Coray T (2006) Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat Med 12, 1005-1015.
88. Kettenmann H, Verkhratsky A (2008) Neuroglia: The 150 years after. Trends Neurosci 31, 653-659.
89. Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40, 140-155.
90. Farina C, Aloisi F, Meinl E (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol 28, 138-145.
91. Bhaskar K, Maphis N, Xu G, Varvel NH, Kokiko-Cochran ON, Weick JP, Staugaitis SM, Cardona A, Ransohoff RM, Herrup K, Lamb BT (2014) Microglial derived tumor necrosis factor-alpha drives Alzheimer's disease-related neuronal cell cycle events. Neurobiol Dis 62, 273-285.
92. Combs CK, Karlo JC, Kao SC, Landreth GE (2001) beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21, 1179-1188.
93. Heurtaux T, Michelucci A, Losciuto S, Gallotti C, Felten P, Dorban G, Grandbarbe L, Morga E, Heuschling P (2010) Microglial activation depends on beta-amyloid conformation: Role of the formylpeptide receptor 2. J Neurochem 114, 576-586.
94. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by beta-amyloid protein and interferongamma. Nature 374, 647-650.
95. Suo Z, Wu M, Citron BA, Wong GT, Festoff BW (2004) Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: An association with early beta-amyloid accumulation. J Neurosci 24, 3444-3452.
96. Gitter BD, Cox LM, Rydel RE, May PC (1995) Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc Natl Acad Sci U S A 92, 10738-10741.
97. Mehlhorn G, Hollborn M, Schliebs R (2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci 18, 423-431.
98. Benzing WC, Wujek JR, Ward EK, Shaffer D, Ashe KH, Younkin SG, Brunden KR (1999) Evidence for glialmediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20, 581-589.
99. Cho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L (2011) CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem 286, 32713-32722.
100. Apelt J, Schliebs R (2001) Beta-amyloid-induced glial expression of both pro-and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res 894, 21-30.
101. Vom Berg J, Prokop S, Miller KR, Obst J, Kalin RE, Lopategui-Cabezas I,Wegner A, Mair F, Schipke CG, Peters O, Winter Y, Becher B, Heppner FL (2012) Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat Med 18, 1812-1819.
102. Ojala JO, Sutinen EM, Salminen A, Pirttila T (2008) Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol 205, 86-93.
103. Ishizuka K, Kimura T, Igata-yi R, Katsuragi S, Takamatsu J, Miyakawa T (1997) Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51, 135-138.
104. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT (2010) Inflammation and Alzheimer's disease. Arch Pharm Res 33, 1539-1556.
105. Cavanagh C, Colby-Milley J, Bouvier D, Farso M, Chabot JG, Quirion R, Krantic S (2013) betaCTF-correlated burst of hippocampal TNFalpha occurs at a very early, pre-plaque stage in theTgCRND8mouse model of Alzheimer's disease. J Alzheimers Dis 36, 233-238.
106. Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ (2005) Early correlation of microglial activation with enhanced tumor necrosis factoralpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2, 23.
107. Wilberding A, Morimoto K, Satoh H, Harano K, Harano T, Arita S, Tooyama I, Konishi Y (2008) Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathology. Tottori Rinsho Kagaku Kenkyukai Shi 1, 359-373.
108. Tarkowski E, Andreasen N, Tarkowski A, Blennow K (2003) Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 74, 1200-1205.
109. Tobinick E (2009) Tumour necrosis factor modulation for treatment of Alzheimer's disease: Rationale and current evidence. CNS Drugs 23, 713-725.
110. Belanger M, Allaman I, Magistretti PJ (2011) Differential effects of pro-and anti-inflammatory cytokines alone or in combinations on the metabolic profile of astrocytes. J Neurochem 116, 564-576.
111. Morita M, Higuchi C, Moto T, Kozuka N, Susuki J, Itofusa R, Yamashita J, Kudo Y (2003) Dual regulation of calcium oscillation in astrocytes by growth factors and proinflammatory cytokines via the mitogen-activated protein kinase cascade. J Neurosci 23, 10944-10952.
112. Santello M, Bezzi P, Volterra A (2011) TNFalpha controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 69, 988-1001.
113. van Kralingen C, Kho DT, Costa J, Angel CE, Graham ES (2013) Exposure to inflammatory cytokines IL-1beta and TNFalpha induces compromise and death of astrocytes; implications for chronic neuroinflammation. PLoS One 8, e84269.
114. Vesce S, Rossi D, Brambilla L, Volterra A (2007) Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol 82, 57-71.
115. Dumont AO, Goursaud S, Desmet N, Hermans E (2014) Differential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-alpha in cortical astrocytes from a rat model of amyotrophic lateral sclerosis. PLoS One 9, e97649.
116. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol 149, 2358-2366.
117. Choi SS, Lee HJ, Lim I, Satoh J, Kim SU (2014) Human astrocytes: Secretome profiles of cytokines and chemokines. PLoS One 9, e92325.
118. Phulwani NK, Esen N, Syed MM, Kielian T (2008) TLR2 expression in astrocytes is induced by TNF-alpha-and NFkappa B-dependent pathways. J Immunol 181, 3841-3849.
119. Benveniste EN, Sparacio SM, Norris JG, Grenett HE, Fuller GM (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J Neuroimmunol 30, 201-212.
120. Norris JG, Tang LP, Sparacio SM, Benveniste EN (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol 152, 841-850.
121. Sawada M, Suzumura A, Marunouchi T (1992) TNF alpha induces IL-6 production by astrocytes but not by microglia. Brain Res 583, 296-299.
122. Didier N, Romero IA, Creminon C, Wijkhuisen A, Grassi J, Mabondzo A (2003) Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J Neurochem 86, 246-254.
123. Han Y, He T, Huang DR, Pardo CA, Ransohoff RM (2001) TNF-alpha mediates SDF-1 alpha-induced NF-kappaBactivation and cytotoxic effects in primary astrocytes. J Clin Invest 108, 425-435.
124. Walsh JG, Muruve DA, Power C (2014) Inflammasomes in the CNS. Nat Rev Neurosci 15, 84-97.
125. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9, 857-865.
126. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678.
127. Liu L, Chan C (2014) IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for Alzheimer's disease. Neurobiol Aging 35, 309-321.
128. Dhawan G, Floden AM, Combs CK (2012) Amyloid-beta oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging 33, 2247-2261.
129. Kim SY, Moon JH, Lee HG, Kim SU, Lee YB (2007) ATP released from beta-amyloid-stimulated microglia induces reactive oxygen species production in an autocrine fashion. Exp Mol Med 39, 820-827.
130. Smits HA, van Beelen AJ, de Vos NM, Rijsmus A, van der Bruggen T, Verhoef J, van Muiswinkel FL, Nottet HS (2001) Activation of human macrophages by amyloid-beta is attenuated by astrocytes. J Immunol 166, 6869-6876.
131. Sheng JG, Mrak RE, GriffinWS(1997) Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol 94, 1-5.
132. Weekman EM, Sudduth TL, Abner EL, Popa GJ, Mendenhall MD, Brothers HM, Braun K, Greenstein A, Wilcock DM (2014) Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice. J Neuroinflammation 11, 127.
133. Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM (2013) Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiol Aging 34, 1051-1059.
134. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P (2009) Characterization of the microglial phenotype under specific pro-inflammatory and antiinflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 210, 3-12.
135. DeWitt DA, Perry G, Cohen M, Doller C, Silver J (1998) Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 149, 329-340.
136. Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA, O'BanionMK(2013) Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J Neurosci 33, 5053-5064.
137. Kraft AW, Hu X, Yoon H, Yan P, Xiao Q, Wang Y, Gil SC, Brown J,Wilhelmsson U, Restivo JL, Cirrito JR, Holtzman DM, Kim J, Pekny M, Lee JM (2013) Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J 27, 187-198.
138. Furman JL, Sama DM, Gant JC, Beckett TL, Murphy MP, Bachstetter AD, Van Eldik LJ, Norris CM (2012) Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. J Neurosci 32, 16129-16140.
139. Ortinski PI, Dong J, Mungenast A,YueC, Takano H,Watson DJ, Haydon PG, Coulter DA (2010) Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13, 584-591.
140. Azizi G, Mirshafiey A (2012) The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis. Immunopharmacol Immunotoxicol 34, 881-895.
141. Gorlovoy P, Larionov S, Pham TT, Neumann H (2009) Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J 23, 2502-2513.
142. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440, 1054-1059.
143. Santello M, Volterra A (2012) TNFalpha in synaptic function: Switching gears. Trends Neurosci 35, 638-647.
144. Li Y, Liu L, Barger SW, Griffin WS (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23, 1605-1611.
145. Moore AH,Wu M, Shaftel SS, Graham KA, O'Banion MK (2009) Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory. Neuroscience 164, 1484-1495.
146. Vezzani A, Baram TZ (2007) New roles for interleukin-1 Beta in the mechanisms of epilepsy. Epilepsy Curr 7, 45-50.
147. DorostkarMM,Herms J (2012) Arc illuminates Alzheimer's pathophysiology. Nat Neurosci 15, 1323-1325.
148. Lai AY, McLaurin J (2012) Inhibition of amyloid-beta peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer disease. Biochim Biophys Acta 1822, 1629-1637.
149. Beckstrom H, Julsrud L, Haugeto O, Dewar D, Graham DI, Lehre KP, Storm-Mathisen J, Danbolt NC (1999) Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease. J Neurosci Res 55, 218-229.
150. Allaman I, Belanger M, Magistretti PJ (2011) Astrocyteneuron metabolic relationships: For better and for worse. Trends Neurosci 34, 76-87.
151. Fuller S, Steele M, Munch G (2010) Activated astroglia during chronic inflammation in Alzheimer's disease - do they neglect their neurosupportive roles? Mutat Res 690, 40-49.
152. Scimemi A, Meabon JS,Woltjer RL, Sullivan JM, Diamond JS, Cook DG (2013) Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1. J Neurosci 33, 5312-5318.
153. Iliff JJ, Chen MJ, PlogBA, ZeppenfeldDM,Soltero M,Yang L, Singh I, Deane R, Nedergaard M (2014) Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34, 16180-16193.
154. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4, 147ra111.
155. Peters O, Schipke CG, Philipps A, Haas B, Pannasch U, Wang LP, Benedetti B, Kingston AE, Kettenmann H (2009) Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice. J Alzheimers Dis 18, 177-189.
156. Rossi D, Brambilla L, Valori CF, Crugnola A, Giaccone G, Capobianco R, Mangieri M, Kingston AE, Bloc A, Bezzi P, Volterra A (2005) Defective tumor necrosis factoralpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. J Biol Chem 280, 42088-42096.
157. Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I, LaFerla FM, Nicoletti F, Cuomo V, Vendemiale G (2012) Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol Aging 33, 1121 e1121-1112.
158. Schallier A, Smolders I,Van Dam D, Loyens E, De Deyn PP, Michotte A, Michotte Y, Massie A (2011) Region-and agespecific changes in glutamate transport in the AbetaPP23 mouse model for Alzheimer's disease. J Alzheimers Dis 24, 287-300.
159. Shrivastava AN, Kowalewski JM, Renner M, Bousset L, Koulakoff A, Melki R, Giaume C, Triller A (2013) betaamyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors. Glia 61, 1673-1686.
160. Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M,Woo DH, Bae JY, Kim T, Lee J, Chun H, Park HJ, Lee da Y, Hong J, Kim HY, Oh SJ, Park SJ, Lee H, Yoon BE, Kim Y, Jeong Y, Shim I, Bae YC, Cho J, Kowall NW, Ryu H, Hwang E, Kim D, Lee CJ (2014) GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat Med 20, 886-896.
161. Wu Z, Guo Z, Gearing M, Chen G (2014) Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzhiemer's disease model. Nat Commus 5, 4159.
162. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ (2009) Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323, 1211-1215.
163. Delekate A, Fuchtemeier M, Schumacher T, Ulbrich C, Foddis M, Petzold GC (2014) Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model. Nat Commus 5, 5422.
164. Lee HS, Ghetti A, Pinto-Duarte A,Wang X, Dziewczapolski G, Galimi F, Huitron-Resendiz S, Pina-Crespo JC, Roberts AJ, Verma IM, Sejnowski TJ, Heinemann SF (2014) Astrocytes contribute to gamma oscillations and recognition memory. Proc Natl Acad Sci U S A 111, E3343-E3352.
165. Noda M, Nakanishi H, Akaike N (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 1465-1474.
166. Takeuchi H, Jin S,Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y, Mizuno T, Suzumura A (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281, 21362-21368.
167. Wu SZ, Bodles AM, Porter MM, Griffin WS, Basile AS, Barger SW (2004) Induction of serine racemase expression and D-serine release from microglia by amyloid betapeptide. J Neuroinflammation 1, 2.
168. Neniskyte U, Neher JJ, Brown GC (2011) Neuronal death induced by nanomolar amyloid beta is mediated by primary phagocytosis of neurons by microglia. J Biol Chem 286, 39904-39913.
169. Brown GC, Neher JJ (2014) Microglial phagocytosis of live neurons. Nat Rev Neurosci 15, 209-216.
170. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM,Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J (2010) Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci 13, 411-413.
171. Neher JJ, Neniskyte U, Brown GC (2012) Primary phagocytosis of neurons by inflamed microglia: Potential roles in neurodegeneration. Front Pharmacol 3, 27.
172. Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H (2015) Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement 11, 58-69.
173. Jack CR Jr, Holtzman DM (2013) Biomarker modeling of Alzheimer's disease. Neuron 80, 1347-1358.
174. Cohen AD, Klunk WE (2014) Early detection of Alzheimer's disease using PiB and FDG PET. Neurobiol Dis 72PA, 117-122.
175. Risacher SL, Saykin AJ (2013) Neuroimaging and other biomarkers for Alzheimer's disease: The changing landscape of early detection. Annu Rev Clin Psychol 9, 621-648.
176. Caselli RJ, Reiman EM (2013) Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention. J Alzheimers Dis 33(Suppl 1), S405-S416.
177. Nestor PJ, Scheltens P, Hodges JR (2004) Advances in the early detection of Alzheimer's disease. Nat Med 10 Suppl, S34-41.
178. Langbaum JB, Fleisher AS, Chen K, Ayutyanont N, Lopera F, Quiroz YT, Caselli RJ, Tariot PN, Reiman EM (2013) Ushering in the study and treatment of preclinical Alzheimer disease. Nat Rev Neurol 9, 371-381.
179. Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R,Walker Z, Kennedy A, Fox N, Rossor M, Brooks DJ (2009) Microglial activation and amyloid deposition in mild cognitive impairment: A PET study. Neurology 72, 56-62.
180. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001) In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467.
181. Schuitemaker A, Dik MG, Veerhuis R, Scheltens P, Schoonenboom NS, Hack CE, Blankenstein MA, Jonker C (2009) Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging 30, 1885-1889.
182. Carter SF, Scholl M, Almkvist O, Wall A, Engler H, Langstrom B, Nordberg A (2012) Evidence for astrocytosis in prodromal Alzheimer disease provided by 11Cdeuterium-L-deprenyl: A multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med 53, 37-46.
183. Choo IL, Carter SF, Scholl ML, Nordberg A (2014) Astrocytosis measured by (1)(1)C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients. Eur J Nucl Med Mol Imaging 41, 2120-2126.
184. Westin K, Buchhave P, Nielsen H, Minthon L, Janciauskiene S, HanssonO(2012) CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease. PLoS One 7, e30525.
185. Kim TS, Lim HK, Lee JY, Kim DJ, Park S, Lee C, Lee CU (2008) Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 436, 196-200.
186. Choi J, Lee HW, Suk K (2011) Increased plasma levels of lipocalin 2 in mild cognitive impairment. J Neurol Sci 305, 28-33.
187. Streit WJ, Braak H, Xue QS, Bechmann I (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 118, 475-485.
188. Webster B, Hansen L, Adame A, Crews L, Torrance M, Thal L, Masliah E (2006) Astroglial activation of extracellularregulated kinase in early stages of Alzheimer disease. J Neuropathol Exp Neurol 65, 142-151.
189. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27, 252-261.
190. Baron R, Babcock AA, Nemirovsky A, Finsen B, Monsonego A (2014) Accelerated microglial pathology is associated with Abeta plaques in mouse models of Alzheimer's disease. Aging Cell 13, 584-595.
191. Yeh CY, Vadhwana B, Verkhratsky A, Rodriguez JJ (2011) Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neuro 3, 271-279.
192. Kulijewicz-Nawrot M,VerkhratskyA, Chvatal A, Sykova E, Rodriguez JJ (2012) Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J Anat 221, 252-262.
193. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ (2010) Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 58, 831-838.
194. Beauquis J, Vinuesa A, Pomilio C, Pavia P, Galvan V, Saravia F (2014) Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease. Hippocampus 24, 257-269.
195. Cerbai F, Lana D, Nosi D, Petkova-Kirova P, Zecchi S, Brothers HM, Wenk GL, Giovannini MG (2012) The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One 7, e45250.
196. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I,Walter J, Klockgether T, Van Leuven F (2005) Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J Neuroinflammation 2, 22.
197. Oberheim NA, Takano T, Han X, HeW, Lin JH,Wang F, Xu Q,Wyatt JD, PilcherW, Ojemann JG, Ransom BR, Goldman SA, Nedergaard M (2009) Uniquely hominid features of adult human astrocytes. J Neurosci 29, 3276-3287.
198. Sosunov AA,Wu X, Tsankova NM, Guilfoyle E, McKhann GM, 2nd, Goldman JE (2014) Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain. J Neurosci 34, 2285-2298.
199. Smith AM, Dragunow M (2014) The human side of microglia. Trends Neurosci 37, 125-135.